PERITONEAL DIALYSIS: GLOBAL UPDATE
|
|
- Joshua Dean
- 6 years ago
- Views:
Transcription
1 Proceedings of the ISPD '98 -The VIIIth Congress of the ISPD /99 $ August 23-26, 1998, Seoul, Korea 1999 International Society for Peritoneal Dialysis Peritoneal Dialysis Internatianal, Vol.19 (1999), Supplement 2 Printed in Canada. All rights reserved. PERITONEAL DIALYSIS: GLOBAL UPDATE Ram Gokal p Manchester RoyalInfirmary, Department of Renal Medicine, Manchester, England eritoneal dialysis has evolved considerably over the last three decades. The dramatic increase in its use was initially related to the introduction of CAPD in Since then, the use ofpd has shown a linear increase. Associated with this dramatic rise in the number of patients on PD have been developments in the associated technology and in understanding pathophysiological mechanisms and complications and the means to overcome them. The result has been an improvement in patient survival rates, now comparable to those for hemodialysis (1), and an improvement in technique survival rates, presently still below that for HD (2). Despite truly impressive technical modifications and improved outcomes, PD technique survival re mains low, and long-term technique survival on PD is limited to between 2% and 4% of patients beyond 5 to 8 years of therapy (3). CURRENT GLOBAL USE OF PERITONEAL DIALYSIS Industrial sources set the total number of patients on dialysis (both PD and HD) to 830,000 at the end of Of the total number, about 30% reside in North America, 21% in Japan, 18% in Europe, and the remainder elsewhere in the world. About 115,000 patients (almost 14% of the total) are managed on PD. The annual growth rate for PD over the last five years has been steady at about 7.5%. It is interesting to assess what percentage of dialysis patients in an individual country are being managed by PD. Fig ures 1 and 2 show the breakdown for various countries in the West and in Asia. The percentages range from below 1% to about 80%. This spread is interesting and does not reflect in any way the merits or demerits of the technique and its suitability (or other wise) for managing patients in end-stage renal dis ease (ESRD). Two recent articles by Nissenson et al (4,5) have clearly delineated non medical factors important in therapy selection. These factors include financial reimbursement policies, physician experience (or lack thereof) with both therapies, patient understanding of modality options, resource availability, social factors, and cultural habits, KEY WORDS: Global PD use; survival; technique failure; dialysis solutions; future developments, Correspondence to: R. Gokal, Consultant Nephrologist, Department of Renal Medicine, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL United Kingdom.
2 Concern over healthcare costs is now escalating greatly everywhere, grounded in changing economic factors. In the United States, the Health Care Finance Administration (HCFA) ESRD program undertook a demonstration project, with emphasis on cost containment and on managing the total cost of care for dialysis patients. Nissenson concludes that in a managed care environment, the ESRD modality that provides the most value (defined as quality/cost) is likely to be the one most utilized (5). In terms of cost, it is recognized that PD patients are substantially less expensive to care for than are HD patients. The difference is related to reduced outpatient costs (mostly owing to the lower cost of dialysis) and reduced inpatient cost (mainly resulting from fewer inpatient stays). The impact of public versus private sector funding has a major influence on the therapy used. For instance, in Europe, in the public sector, 23% of patients were treated by PD, whereas in the private sector the figure was only 3%. Similar figures can be shown for PD in Japan (public sector, 18%; private sector, 3%). SURVIVAL -PATIENT AND TECHNIQUE Various study reports have shown that survival on PD is equivalent to HD (6). However, a true comparison is not possible because no randomized controlled study has been undertaken, and such a study would be almost impossible to perform. Reliance on registry data is therefore necessary, and these data are outlined in Table 1, which shows patient survival at various time intervals. Most of the studies had confounding variables, especially those related to the United State Renal Data System (USRDS) database, which is shows higher death rates in PD patients than in HD patients in a cohort studied at the end of the 1980s (7). The Canadian Organ Replacement Registry (CORR), however, reported on a cohort of patients taken onto dialysis in the early 1990s, and that study quite clearly showed that death rates on HD were higher within all age groups and for both diabetic and non diabetic patients (1). The difference was statistically significant in all patients except diabetics over the age of 65. The low mortality rates for PD were observed even after adjusting for age, primary renal diagnosis, center size, and pre-dialysis comorbid conditions. The reduced mortality for PD appeared to be concentrated in the first two years after initiation of dialysis; survival at five years was not significantly different. These results are quite dramatic, were arrived at in statistically apt ways, and conclusively show that PD is, at a minimum, as good as HD and probably better. Fenton et al (1) concluded that PD is associated with decreased mortality relative to HD, the effect being greatest in the first two years offollow-up. Be cause PD is a more cost-efficient, yet less practiced form of renal replacement therapy, greater use of the therapy may increase access to dialysis by patients and hence save lives. What is still disconcerting is the lower retention rate on PD as compared to HD, which is related to the inherent problems of PD: peritonitis, access, inadequate dialysis, and psychosocial factors (3).
3 Nevertheless, important developments have occurred in these areas. The last decade has seen these landmark PD events: 1. Y-set Study (8), with worldwide introduction of the double bag disconnect systems in the early 1990s. The impact on peritonitis rates has been considerable, and now peritonitis rates of an episode every two to three years are the norm. However, the incidence of serious peritonitis (Staphylococcus aureus, Pseudomonas) has not declined and remains a threat to PD integrity (9). 2. Outcomes shown in the USRDS data (Bloembergen Study) (7) dampened the enthusiasm for PD, especially in the U.S., but now have been countered by data from the Canadian Organ Replacement Registry (CORR Analysis) (1). 3. The CANUSA Study (10) in 1996 initiated the debate for higher solute clearance targets to improve outcomes. It was followed by the National Kidney Foundation's Dialysis Outcomes Quality Initiative (DOQI) guidelines in 1997 (11), which again aimed to improve patient outcomes. 4. The impact of the DOQI guidelines has also spurred introduction and increase in the use of automated PD (APD), facilitated by a new generation of sophisticated, patient-friendly cyclers, introduced in the mid 1990s. OTHER PERITONEAL DIALYSIS DEVELOPMENTS Significant strides have also been made in understanding the pathophysiology of solute and fluid transport, changes in the peritoneal membrane with time, and the need for improved biocompatible solutions to enhance peritoneal membrane integrity. The better understanding of solute transport, based on the three-pore theory (12), now has anatomical counterparts: the aquaporin water transport channel has been identified in the peritoneal mesothelium and capillaries (13), corresponding to the ultra small pores. The peritoneal equilibration test (PET) and its further development, the standard permeability analysis (SPA), enable the identification of deficits in the transport of solutes and fluid (14) by identifying vascular surface area and aquaporin channel integrity. It is now clear that the factors that most greatly affect patient survival are peritoneal permeability, nutrition, and fluid status. In the analysis of the CANUSA data (15), high or high-average permeability was associated with higher death rates, and similar results have been shown in studies in the U.K. (16) These results partly imply that fluid control is poor in these patients, that they are regarded as being "chronically fluid overloaded" (17), and that the fluid overload may magnify the cardiovascular problems that these patients already have (18). Peritoneal membrane damage has been linked to the bioincompatible nature of the PD fluid (hyperosmolality, low ph, the use of glucose, and glucose degradation products) (19). Glucose has been shown to lead to deposition of advanced glycosylation endproduct (AGE) - related products in the peritoneal membrane, leading to increased permeability (20). In vitro studies quite clearly show that hyperosmolality and low ph affect cell function and peritoneal membrane viability (21). New biocompatible solutions are now becoming available with the use of bicarbonate (normal ph) (22), icodextrin (iso-osmolar) (23), and newer, double-chambered glucose solutions with a high ph (24). The use of these solutions has achieved extended time on therapy for patients who have lost ultrafiltration (25). These developments will indeed impact favorably on patient technique survival and longevity. Peritoneal access has been improved by a better catheter (Swan neck), better implantation techniques, and better care (26). The role of S. aureus nasal carriage in exit site infections is especially dramatic: prophylaxis (intranasally or at the exit site) has substantially decreased catheterrelated infections and peritonitis (27,28). FUTURE DEVELOPMENTS Future developments will certainly involve better solution modifications and a profile of solutions to meet individual needs in terms of solute removal, fluid control, blood-pressure control, and perhaps even additives to minimize cardiovascular risk. It is feasible that on-line preparation of PD fluids for home APD therapy will make this therapy cheaper. Early start has been advocated (DOQI guidelines) (11) to try to better preserve residual renal function, to delay the use of blood access sites, to better control salt and water, and to permit continued liberaliza tion of the diet to ensure nutritional rehabilitation. The guidelines would also make it easier to increase the dialysis dose to maintain combined renal and dialysis Kt/V targets and to accommodate incremental dialysis at lower costs. With the introduction of the long-dwell icodextrin solution, it may be possible to use one or two exchanges initially and to increase the number of glucose exchanges gradually as residual renal function declines. There is no doubt that nutritional status declines with declining glomerular filtration rate (GFR) and that the poorer the nutritional state, the worse the outcome. An early start may well be advantageous, but has to be evaluated in conjunction with the potential morbidity of peritoneal dialy
4 sis in patients who may be relatively asymptomatic at the start of dialysis. Another approach in the future may well be to start renal replacement therapy with PD and to shift to HD when the need arises. A preliminary report seems to show prolonged survival of ESRD patients using this approach (29). Future strategies will also focus on the problems ofhigh cardiovascular morbidity and mortality. Interventions likely to impact on these problems include better fluid and bloodpressure control, prevention of permeability changes, and control of lipid and metabolic abnormalities. Overall, the factors that will promote growth in peritoneal dialysis are enhanced survival, economic benefits, product innovations, prescription flexibility, and a shift towards a healthier initiation. The current data indicate that the results of good PD practices are as good or even better than those ofhd. PD has advantages as an initial renal replacement therapy in terms of preserving residual renal function, maintaining nutritional status, and better controlling blood pressure and fluid level. Patient independence and survival are also maintained. It seems that an integrated policy in which transplantation, HD, and PD are equally available -with perhaps the initial therapy in most patients being PD -can improve the survival ofesrd patients. Such a policy would reflect the recognition that well-practiced PD is very cost effective. REFERENCES 1. Fenton SSA, Schaubel DE, Desmeules M, Morrison HI, Mao Y, Copleston P, et al. Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. Am J Kidney Dis. 1997; 30: Maiorca R, Cancarini G, Zubani R, Camerini C, Manili L, Brimori G, et al. CAPD viability: A long-term comparison with hemodialysis. Perit Dial Int. 1996; 16: Gokal R, Oreopoulos D. Is long term CAPD possible? Perit Dial Int. 1996; 16: Nissenson AR, Prichard SS, Cheng I, Gokal R, Kubota M, Maiorca R, et al. Non-medical factors that impact on ESRD modality selection. Kidney Int. 1993; 38(SuppI40):SI Nissenson AR, Prichard SS, Cheng IPS, Gokal R, Kubota M, Maiorca R, et al. ESRD modality selection into the 21st century: The impact of non-medical factors. ASAIO J. 1997; 43: Nolph KD. Why are reported relative mortality risks for CAPD and HD so variable? Perit Dial Int. 1996; 16: Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of mortality between patients treated with haemodialysis and peritoneal dialysis. J Am Soc Nephrol. 1995; 6: Churchill DN, Taylor DW, Vas SI, and the Canadian CAPD Clinical Trials Group. Peritonitis in CAPD: A multicentre randomised clinical trial comparing the y-connector disinfectant system to standard system. Perit Dial Int. 1989; 9: Holley JL, Bernardini J, Piraino B. Infecting organisms in continuous ambulatory peritoneal dialysis patients on the y- set.am J Kidney Dis. 1994; 23: Canada-U.S.A. (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol. 1996; 7: National Kidney Foundation Dialysis Outcomes Quality Initiative. Clinical practice guidelines for peritoneal dialysis adequacy.am J Kidney Dis. 1997; 30(Suppl 2):S Flessner MF. Peritoneal transport physiology: Insights from basic research. J Am Sac Nephrol.1991; 2: Ho-dac-Pannekeet MM, Krediet RT. Water channels in the peritoneum. Perit Dial Int. 1996; 16: Ho-dac-Pannekeet MM, Atasever B, Struijk DG, Krediet RT. Analysis of ultrafiltration failure in peritoneal dialysis patients by means of a standard permeability analysis (SPA). Perit Dial Int. 1997; 17: Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D. Increased peritoneal transport - association with decreased patient and technique survival. J Am Soc Nephrol. 1998; 9: Davies SJ, Bryan J, Phillips L, Russell GI. Longitudinal changes in peritoneal kinetics: The effects ofperitoneal dialysis and peritonitis. Nephrol Dial Transplant. 1996; 11: Rottembourg J. Residual renal function and recovery of renal function in patients treated by CAPD. Kidney Int. 1993; 43(SuppI40):SI Coles GA. Have we underestimated the importance of fluid balance for the survival ofpd patients? Perit Dial Int. 1997; 17: Jörres A, Williams JD, Topley N. Peritoneal dialysis solution biocompatibility: Inhibitory mechanisms and recent studies with bicarbonate buffered solutions. Perit Dial Int. 1997; 17(Suppl 2):S Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katoh N, et al. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int. 1997; 51: Gotloib L, Shostak A, Wajsbrot V. Detrimental effects of peritoneal dialysis solutions upon in vivo and in situ exposed mesothelium. Perit Dial Int. 1997; 17(Suppl 2): SI Coles G, Gokal R, Ogg C, Jani F, O'Donoghue D, Cancarini G, et al. A randomized controlled trial of a bicarbonate and bicarbonate/lactate containing dialysis fluid in CAPD. Perit Dial Int. 1997; 17: Peers E, Gokal R. Icodextrin: Overview of clinical ex perience. Perit Dial Int. 1997; 17: Rippe B, Simonsen 0, Wieslander A, Landren C. Clini cal and physiological effects of a new, less toxic and less acidic fluid for peritoneal dialysis. Perit Dial Int.
5 1997; 17: Wilkie ME, Plant MJ, Edwards J, Brown C. Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: Extension of CAPD technique survival. Perit Dial Int. 1997; 17: Gokal R, Alexander S, Ash S, Chen W, Danielson A, Holmes C, et al. Peritoneal catheter and exit site practices towards optimum peritoneal access: 1998 update. Perit Dial Int. 1998; 18: The Mupirocin Study Group. Nasal mupirocin prevents Staphylococcus aureus exit-site infections during peritoneal dialysis. J Am Soc Nephrol. 1997; 11: Thodis E, Bhaskaran S, Pasadakis P, Bargman J, Vas SI, Oreopoulos DG. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application ofmupirocin ointment at the catheter exit site. Perit Dial Int. 1998; 18: Van Biesen W, De Vogeleere P, Vijt D, Vanholder R, Lameire N. Integrated care can improve long-term survival of ESRD patients [Abstract]. Perit Dial Int. 1998; 18: Charytan C, Spinovitz BS, Galler M. A comparative study of CAPD and in centre HD. Arch Intern Med. 1986; 146: Burton PR, Walls J.A selection adjusted comparison of life expectancy of pat ients on CAPD, haemodialysis and renal transplantation. Lancet. 1987; 1: Gokal R, Jakubowski C, King C, Hunt L, Boyle S, Baillod R, et al. Outcome in patients on CAPD and hemodialysis: A four year analysis of a prospective multicentre study. Lancet. 1987; ii: Serkes KD, Blagg CR, Nolph KD, Vonesh E, Shapiro F. Comparison of patients and techniques in CAPD and hemodialysis: A multi-center study. Perit Dial Int. 1990; 10: Cavalli P, Viglino G, Goia F, Cottino R, Mariano F, Gandolfo C. CAPD versus hemodialysis: 7 years experience. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in Peri toneal Dialysis. Toronto: Peritoneal Dialysis Bulletin, 1989; 5: Maiorca R, Vonesh EF, Cavalli PL, De Vecchi A, Giangrande A, LaGreca G, et al. A multicentre selection adjusted comparison of patient and technique survival on CAPD and hemodialysis. Perit Dial Int. 1991; 11: Disney APS, for the Australia and New Zealand Dialysis and Transplant Registry. Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand. Am J Kidney Dis. 1995; 25: Mallick NP, Jones E, Selwood N. The European (European Dialysis and Transplantation Association -European Renal Association) Registry. Am J Kidney Dis. 1995; 25: Lupo A, Tarchini R, Cancarini G, Catizone L, Cocchi R, De Vecchi A, et al. Long term outcome in CAPD: A 10 year survey by the Italian Cooperative Peritoneal Dialysis Study Group. Am J Kidney Dis.1994; 24: Teraoka S, Toma H, Nihei H, Ota K, Babazono T, Ishikawa I, et al. Current status of renal replacement therapy in Japan. Am J Kidney Dis. 1995; 25: HeldPJ,PortFK, TurenneMN,GaylinDS,Hamburger RT, Wolfe RA. CAPD and hemodialysis: Comparison of patient mortality with adjustment for comorbid conditions. Kidney Int. 1994; 45:
3/21/2017. Solute Clearance and Adequacy Targets in Peritoneal Dialysis. Peritoneal Membrane. Peritoneal Membrane
3/21/2017 Solute Clearance and Adequacy Targets in Peritoneal Dialysis Steven Guest MD Director, Medical Consulting Services Baxter Healthcare Corporation Deerfield, IL, USA Peritoneal Membrane Image courtesy
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Peritoneal transport and ultrafiltration GUIDELINES
Date written: January 2004 Final submission: May 2004 Peritoneal transport and ultrafiltration GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationAdvances in Peritoneal Dialysis, Vol. 23, 2007
Advances in Peritoneal Dialysis, Vol. 23, 2007 Antonios H. Tzamaloukas, 1,2 Aideloje Onime, 1,2 Dominic S.C. Raj, 2 Glen H. Murata, 1 Dorothy J. VanderJagt, 3 Karen S. Servilla 1,2 Computation of the Dose
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Mode of dialysis at initiation GUIDELINES
Date written: September 2004 Final submission: February 2005 Mode of dialysis at initiation GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Monitoring patients on peritoneal dialysis GUIDELINES
Date written: August 2004 Final submission: July 2005 Monitoring patients on peritoneal dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationEarly Estimation of High Peritoneal Permeability Can Predict Poor Prognosis for Technique Survival in Patients on Peritoneal Dialysis
Advances in Peritoneal Dialysis, Vol. 22, 2006 Hidetomo Nakamoto, 1,2 Hirokazu Imai, 2 Hideki Kawanishi, 2 Masahiko Nakamoto, 2 Jun Minakuchi, 2 Shinichi Kumon, 2 Syuichi Watanabe, 2 Yoshhiko Shiohira,
More informationTreated ESRD Incidence Rate for Selected Countries, New Patients/Million Pop. 250 USA (All) USRDS 1996
Annual Data Report International Comparisons of ESRD Therapy Chapter XI International Comparisons of ESRD Therapy O ver the last decade a growing number of national and regional registries dealing with
More informationPresternal Catheter Design An Opportunity to Capitalize on Catheter Immobilization
Advances in Peritoneal Dialysis, Vol. 26, 2010 Dale G. Zimmerman Presternal Catheter Design An Opportunity to Capitalize on Catheter Immobilization Effective immobilization of the peritoneal catheter has
More informationMaintaining Peritoneal Dialysis Adequacy: The Process of Incremental Prescription
Advances in Peritoneal Dialysis, Vol. 34, 2018 Susie Q. Lew Maintaining Peritoneal Dialysis Adequacy: The Process of Incremental Prescription Urea kinetics (weekly Kt/V) greater than 1.7 generally define
More informationPeritoneal dialysis in the US: Evaluation of outcomes in contemporary cohorts
http://www.kidney-international.org & 2006 International Society of Nephrology Peritoneal dialysis in the US: Evaluation of outcomes in contemporary cohorts S Mujais 1 and K Story 1 1 Renal Division, Baxter
More informationUSRDS 1997 Annual Data Report International Comparisons of ESRD Therapy. Treated ESRD Incidence Rate for Selected Countries,
Annual Data Report International Comparisons of ESRD Therapy Chapter XII International Comparisons of ESRD Therapy Key Words: ESRD registry ESRD prevalence Dialysis modality Renal transplantation ESRD
More informationThe peritoneal equilibration test (PET) was developed THE SHORT PET IN PEDIATRICS. Bradley A. Warady and Janelle Jennings
Peritoneal Dialysis International, Vol. 27, pp. 441 445 Printed in Canada. All rights reserved. 0896-8608/07 $3.00 +.00 Copyright 2007 International Society for Peritoneal Dialysis THE SHORT PET IN PEDIATRICS
More informationChapter 2 Peritoneal Equilibration Testing and Application
Chapter 2 Peritoneal Equilibration Testing and Application Francisco J. Cano Case Presentation FW, a recently diagnosed patient with CKD Stage 5, is a 6-year-old boy who has been recommended to initiate
More informationConcern about the decreasing use of peritoneal dialysis
Page 1 of 8 Peritoneal Dialysis International Peritoneal Dialysis International, Vol. 30, pp. doi: 10.3747/pdi.2008.00277 0896-8608/10 $3.00 +.00 Copyright 2010 International Society for Peritoneal Dialysis
More informationVolume Management 2/25/2017. Disclosures statement: Objectives. To discuss evaluation of hypervolemia in peritoneal dialysis patients
Volume Management Sagar Nigwekar MD, MMSc Massachusetts General Hospital E-mail: snigwekar@mgh.harvard.edu March 14, 2017 Disclosures statement: Consultant: Allena, Becker Professional Education Grant
More informationThe dilemma in pursuing dialysis in developing
Proceedings of the ISPD 2001 The IXth Congress of the ISPD June 26 29, 2001, Montréal, Canada Peritoneal Dialysis International, Vol. 21 (2001), Supplement 3 0896-8608/01 $3.00 +.00 Copyright 2001 International
More informationof life: haemodialysis versus peritoneal dialysis patients
Original Article Singapore Med J 2009; 50 (2) : 185 Comparison of outcome and quality of life: haemodialysis versus peritoneal dialysis patients Noshad H, Sadreddini S, Nezami N, Salekzamani Y, Ardalan
More informationProceedings of the ISPD 2006 The 11th Congress of the ISPD /07 $ MAXIMIZING THE SUCCESS OF PERITONEAL DIALYSIS IN HIGH TRANSPORTERS
Proceedings of the ISPD 2006 The 11th Congress of the ISPD 0896-8608/07 $3.00 +.00 August 25 29, 2006, Hong Kong Copyright 2007 International Society for Peritoneal Dialysis Peritoneal Dialysis International,
More informationPeritoneal Dialysis Adequacy: Not Just Small- Solute Clearance
Advances in Peritoneal Dialysis, Vol. 24, 2008 Rajesh Yalavarthy, Isaac Teitelbaum Peritoneal Dialysis Adequacy: Not Just Small- Solute Clearance Two indices of small-solute clearance, Kt/V urea and creatinine
More informationAna Paula Bernardo. CHP Hospital de Santo António ICBAS/ Universidade do Porto
Ana Paula Bernardo CHP Hospital de Santo António ICBAS/ Universidade do Porto Clinical relevance of hyperphosphatemia Phosphate handling in dialysis patients Phosphate kinetics in PD peritoneal phosphate
More informationClinical Practice Guidelines : 3b - Peritoneal Dialysis. UK Renal Association Clinical Practice Guidelines 5th Edition 2007
Clinical Practice Guidelines : 3b - Peritoneal Dialysis UK Renal Association Clinical Practice Guidelines 5th Edition 2007 Prof Simon Davies Department of Nephrology University Hospital of North Staffordshire
More informationObjectives. Peritoneal Dialysis vs. Hemodialysis 02/27/2018. Peritoneal Dialysis Prescription and Adequacy Monitoring
Peritoneal Dialysis Prescription and Adequacy Monitoring Christine B. Sethna, MD, EdM Division Director, Pediatric Nephrology Cohen Children s Medical Center Associate Professor Hofstra Northwell School
More informationAn Evaluation of an Integrative Care Approach for End-Stage Renal Disease Patients
J Am Soc Nephrol 11: 116 125, 2000 An Evaluation of an Integrative Care Approach for End-Stage Renal Disease Patients WIM VAN BIESEN, RAYMOND C. VANHOLDER, NIC VEYS, ANNEMIEKE DHONDT, and NORBERT H. LAMEIRE
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Guidelines
6. Type of peritoneal dialysis Date written: February 2003 Final submission: May 2004 Guidelines No peritoneal dialysis has proven to be superior to the two cuff standard Tenckhoff in the prevention of
More informationTidal peritoneal dialysis: Comparison of different tidal regimens and automated peritoneal dialysis
Kidney International, Vol. 57 (2000), 2603 2607 Tidal peritoneal dialysis: Comparison of different tidal regimens and automated peritoneal dialysis PETER H. JUERGENSEN, A. LOLA MURPHY, KATHY A. PHERSON,
More informationThe greatest benefit of peritoneal dialysis (PD) is the
Peritoneal Dialysis International, Vol. 26, pp. 150 154 Printed in Canada. All rights reserved. 0896-8608/06 $3.00 +.00 Copyright 2006 International Society for Peritoneal Dialysis COMBINATION THERAPY
More informationIntermittent peritoneal dialysis (IPD) has occasionally
Peritoneal Dialysis International, Vol. 32, pp. 142 148 doi: 10.3747/pdi.2011.00027 0896-8608/12 $3.00 +.00 Copyright 2012 International Society for Peritoneal Dialysis INTERMITTENT PERITONEAL DIALYSIS:
More informationEffect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations
NDT Advance Access published November 9, 2005 Nephrol Dial Transplant (2005) 1 of 8 doi:10.1093/ndt/gfi248 Original Article Effect of previously failed kidney transplantation on peritoneal dialysis outcomes
More informationPART ONE. Peritoneal Kinetics and Anatomy
PART ONE Peritoneal Kinetics and Anatomy Advances in Peritoneal Dialysis, Vol. 22, 2006 Paul A. Fein, Irfan Fazil, Muhammad A. Rafiq, Teresa Schloth, Betty Matza, Jyotiprakas Chattopadhyay, Morrell M.
More informationPERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT GUIDE
PERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT GUIDE TABLE OF CONTENTS Introduction.... 3 SECTION 1: FUNDAMENTALS OF THE PRESCRIPTION.... 4 Getting Started: Patient Pathway to First Prescription.... 5 Volume
More informationPRESERVATION OF RESIDUAL RENAL FUNCTION IN DIALYSIS PATIENTS: EFFECTS OF DIALYSIS-TECHNIQUE RELATED FACTORS
Peritoneal Dialysis International, Vol. 21, pp. 52 57 Printed in Canada. All rights reserved. 0896-8608/00 $3.00 +.00 Copyright 2001 International Society for Peritoneal Dialysis PRESERVATION OF RESIDUAL
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Level of renal function at which to initiate dialysis GUIDELINES
Level of renal function at which to initiate dialysis Date written: September 2004 Final submission: February 2005 GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR
More informationSequential peritoneal equilibration test: a new method for assessment and modelling of peritoneal transport
Nephrol Dial Transplant (2013) 28: 447 454 doi: 10.1093/ndt/gfs592 Sequential peritoneal equilibration test: a new method for assessment and modelling of peritoneal transport Magda Galach 1, Stefan Antosiewicz
More information6. Type of peritoneal dialysis catheter
Blackwell Science, LtdOxford, UKNEPNephrology1320-53582004 Asian Pacific Society of NephrologyOctober 20049S3S59S64MiscType of peritoneal dialysis The CARI Guidelines NEPHROLOGY 2004; 9, S59 S64 Date written:
More informationContinuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis: What, Who, Why, and How? Review and Case Study
Advances in Peritoneal Dialysis, Vol. 33, 2017 Kunal Malhotra, Ramesh Khanna Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis: What, Who, Why, and How? Review and Case Study
More informationPART FOUR. Metabolism and Nutrition
PART FOUR Metabolism and Nutrition Advances in Peritoneal Dialysis, Vol. 22, 2006 Costas Fourtounas, Eirini Savidaki, Marilena Roumelioti, Periklis Dousdampanis, Andreas Hardalias, Pantelitsa Kalliakmani,
More informationPatient and technique survival on peritoneal dialysis in patients with failed renal allograft: A case control study
http://www.kidney-international.org & 2006 International Society of Nephrology Patient and technique survival on peritoneal dialysis in patients with failed renal allograft: A case control study S Mujais
More information2016 Annual Dialysis Conference Michelle Hofmann RN, BSN, CNN Renal Clinical Educator - Home
Fluid Management 2016 Annual Dialysis Conference Michelle Hofmann RN, BSN, CNN Renal Clinical Educator - Home Objectives Define euvolemia Determine factors which contribute to fluid imbalance Discuss strategies
More informationPERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT QUICK REFERENCE GUIDE
PERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT QUICK REFERENCE GUIDE This quick reference guide will help serve as a reference tool for clinicians setting a patient s Peritoneal Dialysis (PD) prescription.
More informationOriginal Article. Key words: Icodextrin, peritoneal dialysis, metabolic effects, ultrafiltration
Original Article 133 Clinical Experience of One-Year Icodextrin Treatment in Peritoneal Dialysis Patients Chun-Shuo Hsu *, Chien-Yu Su **, Chih-Hung Chang ***, Kao-Tai Hsu **, King-Kwan Lam **, Shang-Chih
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Blood urea sampling methods GUIDELINES
Date written: November 2004 Final submission: July 2005 Blood urea sampling methods GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions are
More informationIncreased peritoneal dialysis utilization and improved patient survival over a 20-year period: data from a Portuguese Peritoneal Dialysis Unit
ORIGINAL ARTICLE Port J Nephrol Hypert 2016; 30(2): 113-120 Advance Access publication 30 January 2016 Increased peritoneal dialysis utilization and improved patient survival over a 20-year period: data
More informationExperts in all modalities The Expanding Role of PD Trends and Advances That Have Increased the Viability and Utilization of Peritoneal Dialysis
Experts in all modalities The Expanding Role of PD Trends and Advances That Have Increased the Viability and Utilization of Peritoneal Dialysis Todd W.B. Gehr, M.D. Professor and Chairman, Division of
More informationChapter 2 Current Status of Peritoneal Dialysis
Chapter 2 Current Status of Peritoneal Dialysis R. Mehrotra and E.W. Boeschoten It was in 1923 that Ganter performed the first peritoneal dialysis (PD) in a woman with renal failure [1]. However, the early
More informationCLINICAL PRACTICE GUIDELINES. Peritoneal Dialysis. UK Renal Association. Final Draft Version ( ) Dr Graham Woodrow & Prof Simon Davies
CLINICAL PRACTICE GUIDELINES Peritoneal Dialysis UK Renal Association 5 th Edition, 2009-2012 Final Draft Version (09.05.10) Dr Graham Woodrow & Prof Simon Davies Posted at www.renal.org/guidelines Please
More informationPeritoneal dialysis adequacy: A model to assess feasibility with various modalities
Kidney International, Vol. 55 (1999), pp. 2493 2501 Peritoneal dialysis adequacy: A model to assess feasibility with various modalities JOSE A. DIAZ-BUXO, FRANK A. GOTCH, TOM I. FOLDEN, SHELDEN ROSENBLUM,
More informationWhat is a PET? Although there are many types of pets, we will be discussing the Peritoneal Equilibration Test
1 2 3 What is a PET? Although there are many types of pets, we will be discussing the Peritoneal Equilibration Test 4 Background information about the PET 1983 Dr. Twardowski and colleagues began measuring
More informationThe low ph of conventional peritoneal dialysis (PD) solutions,
Peritoneal Dialysis International, Vol. 29, pp. 158 162 Printed in Canada. All rights reserved. 0896-8608/09 $3.00 +.00 Copyright 2009 International Society for Peritoneal Dialysis EFFECTS OF IONIZED SODIUM
More informationHyperphosphatemia is a strong predictor of overall
Peritoneal Phosphate Clearance is Influenced by Peritoneal Dialysis Modality, Independent of Peritoneal Transport Characteristics Sunil V. Badve,* Deborah L. Zimmerman,* Greg A. Knoll, * Kevin D. Burns,*
More informationSt George & Sutherland Hospitals PERITONEAL DIALYSIS UNIT RENAL DEPARTMENT Workplace Instruction (Renal_SGH_WPI_097)
PERITONEAL DIALYSIS (PD) PERITONEAL EQUILIBRATION TEST (PET) Cross references NSW Health PD2007_036 - Infection Control Policy SGH-TSH CLIN027 - Aseptic Technique - Competency and Education Requirements
More informationKDIGO Controversies Conference on Dialysis Initiation, Modality Choice and Prescription. January 25 28, 2018 Madrid, Spain
KDIGO Controversies Conference on Dialysis Initiation, Modality Choice and Prescription January 25 28, 2018 Madrid, Spain Kidney Disease: Improving Global Outcomes (KDIGO) is an international organization
More informationfor comorbid conditions
Kidney International, Vol. 45 (1994), pp. 1163 1169 Continuous ambulatory peritoneal dialysis and hemodialysis: Comparison of patient mortality with adjustment for comorbid conditions PHILIP J. HELD, FRIEDRICH
More informationPeritoneal Transport: From Basics to Bedside
Review Article Peritoneal Transport: From Basics to Bedside Tao Wang, Bengt Lindholm 1 Comprehensive understanding of peritoneal solute and fluid transport is of clinical significance to nephrologists
More informationChanging the Paradigm from Contraction of Peritoneal Dialysis Programs to Increasing Prevalent Peritoneal Dialysis Numbers
Advances in Peritoneal Dialysis, Vol. 29, 2013 Jennifer Cross, Andrew Davenport Changing the Paradigm from Contraction of Peritoneal Dialysis Programs to Increasing Prevalent Peritoneal Dialysis Numbers
More informationTransition between home dialysis modalities another piece in the jigsaw of the integrated care pathway.
Transition between home dialysis modalities another piece in the jigsaw of the integrated care pathway. Mark Lambie and Simon J Davies Health Services Research Unit, Institute for Science and Technology
More informationEvaluation and management of nutrition in children
Evaluation and management of nutrition in children Date written: May 2004 Final submission: January 2005 Author: Elisabeth Hodson GUIDELINES No recommendations possible based on Level I or II evidence
More informationRenal Replacement Therapies
Renal Replacement Therapies M I H Á L Y T A P O L Y A I, M D, F A S N, F A C P A s s o c i a t e P r o f e s s o r D e p a r t m e n t o f N e p h r o l o g y L o u i s i a n a S t a t e U n i v e r s
More informationTHERAPEUTIC INTERVENTIONS TO PRESERVE RESIDUAL KIDNEY FUNCTION. Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle
THERAPEUTIC INTERVENTIONS TO PRESERVE RESIDUAL KIDNEY FUNCTION Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle 1 2 Outline of Presentation Refinements in our understanding
More informationDaily peritoneal ultrafiltration predicts patient and technique survival in anuric peritoneal dialysis patients
2322 X. Lin et al. gy data. Journal of the American Statistical Association 1993; 88: 400 409 32. Bodnar E, Blackstone EH. An actual problem: another issue of apples and oranges. J Thorac Cardiovasc Surg
More informationAutomated peritoneal dialysis (APD) has, in recent
VIIth International Course on Peritoneal Dialysis May 23 26, 2000, Vicenza, Italy Peritoneal Dialysis International, Vol. 20, Suppl. 2 0896-8608/00 $3.00 +.00 Copyright 2000 International Society for Peritoneal
More informationChapter III. Treatment Modalities for ESRD Patients. Treatment Modality Options
USRDS 1996 Annual Data Report Chapter III R enal replacement therapy for patients with ESRD includes several options, the main categories being renal transplantation, hemodialysis, and peritoneal dialysis.
More informationWHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington
WHEN (AND WHEN NOT) TO START DIALYSIS Shahid Chandna, Ken Farrington Changing Perspectives Beta blockers 1980s Contraindicated in heart failure Now mainstay of therapy HRT 1990s must Now only if you have
More informationYour Kidney Health. Your Choices. Chronic Kidney Disease
Your Kidney Health Your Choices Your doctor may have told you that you have chronic kidney disease (CKD or advanced kidney disease; or, you may be in kidney failure, and may have to make a decision about
More informationMETABOLISM AND NUTRITION WITH PD OBESITY. Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle
METABOLISM AND NUTRITION WITH PD OBESITY Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle 1 Body Size in Patients New to Dialysis United States Body Mass Index, kg/m2 33 31
More informationTime trends in initiation and dose of dialysis in end-stage renal disease patients in The Netherlands
Nephrol Dial Transplant (2003) 18: 552 558 Original Article Time trends in initiation and dose of dialysis in end-stage renal disease patients in The Netherlands Fabian Termorshuizen 1, Johanna C. Korevaar
More informationInfluence of ph-neutral Peritoneal Dialysis Solution
Advances in Peritoneal Dialysis, Vol. 18, 2002 Misaki Moriishi, Hideki Kawanishi, Tooru Kawai, Syunsake Takahashi, Takayuki Hirai, Masayaki Shishida, Hiroshi Watanabe, Naoko Takahashi Influence of ph-neutral
More informationISPD Asian Chapter Newsletter International Society for Peritoneal Dialysis (ISPD)
ISPD Asian Chapter Newsletter International Society for Peritoneal Dialysis (ISPD) Volume 6, Issue 2; August 2008 From the Editorial Office Dear All, Welcome back from the 2008 ISPD congress held in Istanbul,
More informationTalking with Patients About Home Therapies
Talking with Patients About Home Therapies Sherri L. Bresn BS, BSN, RN, CNN 1 This presentation is not intended to replace the medical diagnosis, and/or prescription for therapy as determined by a practicing
More informationThe Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival
ORIGINAL ARTICLE DOI: 10.3904/kjim.2009.24.1.55 The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival Seoung Gu Kim 1 and Nam Ho Kim 2 Department of Internal Medicine,
More information02/21/2017. Assessment of the Peritoneal Membrane: Practice Workshop. Objectives. Review of Physiology. Marina Villano, MSN, RN, CNN
Assessment of the Peritoneal Membrane: Practice Workshop Marina Villano, MSN, RN, CNN marina.villano@fmc-na.com Objectives Briefly review normal peritoneal physiology including the three pore model. Compare
More informationAdequacy of automated peritoneal dialysis with and without manual daytime exchange: A randomized controlled trial
http://www.kidney-international.org & 2006 International Society of Nephrology original article Adequacy of automated peritoneal dialysis with and without manual daytime exchange: A randomized controlled
More informationAPD and its new frontier. Roberto Pecoits-Filho, MD, PhD, FACP, FASN
APD and its new frontier Roberto Pecoits-Filho, MD, PhD, FACP, FASN STARCH Study Phase IV Randomised (1:1) Parallel groups Multi-centre Nephrol Dial Transpl 2015 Nov;30(11):1905-11. Non-diabetic APD
More informationLong-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function
Nephrol Dial Transplant (2001) 16: 2207 2213 Original Article Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function Murali K. Menon,
More informationChapter 12 PERITONEAL DIALYSIS
Chapter 12 PERITONEAL DIALYSIS B. Sunita A/P V. Bavanandan Anita Bhajan Manocha Lily Binti Mushahar Mohamad Zaimi Bin Abdul Wahab Sudhaharan Sivathasan PERITONEAL DIALYSIS 22nd Report of the SECTION 12.1:
More informationDrug Use in Dialysis
(Last Updated: 08/22/2018) Created by: Socco, Samantha Drug Use in Dialysis Drambarean, B. (2017). Drug Use in Dialysis. Lecture presented at PHAR 503 Lecture in UIC College of Pharmacy, Chicago. DIALYSIS
More informationSuccessful long-term peritoneal dialysis (PD) requires
Proceedings of the ISPD 2001 The IXth Congress of the ISPD June 26 29, 2001, Montréal, Canada Peritoneal Dialysis International, Vol. 21 (2001), Supplement 3 0896-8608/01 $3.00 +.00 Copyright 2001 International
More informationAcid-base profile in patients on PD
Kidney International, Vol. 6, Supplement 88 (23), pp. S26 S36 Acid-base profile in patients on PD SALIM MUJAIS Renal Division, Baxter Healthcare Corporation, McGaw Park, Illinois Acid-base profile in patients
More informationStrategies to Prevent Peritoneal Dialysis Failure
Strategies to Prevent Peritoneal Dialysis Failure Constantinos J. Stefanidis, MD, PhD P & A Kyriakou Children s Hospital, Athens, Greece Technique failure Drop-out Transfer to HD Technique failure rate
More informationClinical Practice Guideline Peritoneal Dialysis in Adults and Children
Clinical Practice Guideline Peritoneal Dialysis in Adults and Children Final Version: June 2017 Review Date: June 2022 Authors: Dr Graham Woodrow - Chair Consultant Nephrologist, St James s University
More informationRenal Association Clinical Practice Guideline on peritoneal dialysis in adults and children
Woodrow et al. BMC Nephrology (2017) 18:333 DOI 10.1186/s12882-017-0687-2 CORRESPONDENCE Renal Association Clinical Practice Guideline on peritoneal dialysis in adults and children Graham Woodrow 1*, Stanley
More informationThe Sudan Peritoneal Dialysis Program: Three Years of Momentum
Original Article AJNT The Sudan Peritoneal Dialysis Program: Three Years of Momentum Hasan Abu-Aisha a, Elwaleed AM Elhassan b*, Sarra Elamin c a. FRCP, Professor of medicine and nephrology, National Ribat
More informationImprovement in Pittsburgh Symptom Score Index After Initiation of Peritoneal Dialysis
Advances in Peritoneal Dialysis, Vol. 24, 2008 Matthew J. Novak, 1 Heena Sheth, 2 Filitsa H. Bender, 1 Linda Fried, 1,3 Beth Piraino 1 Improvement in Pittsburgh Symptom Score Index After Initiation of
More informationPREDICTORS OF PERITONITIS AMONG CANADIAN PERITONEAL DIALYSIS PATIENTS
PREDICTORS OF PERITONITIS AMONG CANADIAN PERITONEAL DIALYSIS PATIENTS By Sharon J. Nessim, MD A thesis submitted in conformity with the requirements for the degree of Master of Science Graduate Department
More informationFree water transport: Clinical implications. Sodium sieving during short very hypertonic dialysis exchanges
Free water transport: Clinical implications Raymond T Krediet, MD,PhD University of Amsterdam Sodium sieving during short very hypertonic dialysis exchanges Nolph KD et al. Ann Int Med 1969;70:931-947
More informationEARLY CLINICAL STUDIES
Peritoneal Dialysis International, Vol. 17, pp 22-26 0896-8608/97 $300 + 00 Printed in Canada All rights reserved Copyright @ 1997 International Society for Peritoneal Dialysis ICODEXTRIN: OVERVIEW OF
More informationPeritoneal Dialysis Solutions. Cristina Lage Medical Affairs and Information
Peritoneal Dialysis Solutions Cristina Lage Medical Affairs and Information 1 Standard, single-chambered FME PD solutions - composition * Electrolytes to maintain balance Sodium 134-140 mmol/l Potassium
More informationEffect of Initial PET Status on Clinical Course in Peritoneal Dialysis Patients
BANTAO Journal 2015; 13(1): 14-19; doi:10.1515/bj-2015-0004 BJ BANTAO Journal Original article Effect of Initial PET Status on Clinical Course in Peritoneal Dialysis Patients Tamer Sakaci¹, Yener Koc²,
More informationPredictors of Patient Survival in Continuous Ambulatory Peritoneal Dialysis 10-Year Experience in 2 Major Centers in Tehran
Dialysis Predictors of Patient Survival in Continuous Ambulatory Peritoneal Dialysis 10-Year Experience in 2 Major Centers in Tehran Monir Sadat Hakemi, 1 Mehdi Golbabaei, 2 Amirahmad Nassiri, 3 Mandana
More informationUnited States Renal Data System (USRDS) International Data Collection Form
United States Renal Data System (USRDS) International Data Collection Form This form is designed to solicit information on the population of End-Stage Renal Disease (ESRD) patients in your country who
More informationPeritoneal Dialysis Prescriptions: A Primer for Nurses
Peritoneal Dialysis Prescriptions: A Primer for Nurses A Primer ABCs of PD R x Betty Kelman RN-EC MEd CNeph (C) Toronto General Hospital University Health Network Toronto, Ontario, Canada A moment to remember
More informationChanges in Patient and Technique Survival over Time among Incident Peritoneal Dialysis Patients in Canada
Article Changes in Patient and Technique Survival over Time among Incident Peritoneal Dialysis Patients in Canada Jeffrey Perl,* Ron Wald,* Joanne M. Bargman, Yingbo Na, S. Vanita Jassal, Arsh K. Jain,
More informationPD prescribing for all. QUESTION: Which approach? One size fits all or haute couture? (1) or (2)? The patient 18/03/2014.
PD prescribing for all Pr Max Dratwa Honorary consultant, Nephrology-Dialysis CHU Brugmann Université Libre de Bruxelles BSN 22 March 2014 QUESTION: Which approach? One size fits all or haute couture?
More informationFrom Peritoneal Dialysis to Hemodialysis How could we improve the transition? Th Lobbedez CHU de Caen Self Dialysis Meeting 22 May 2014
From Peritoneal Dialysis to Hemodialysis How could we improve the transition? Th Lobbedez CHU de Caen Self Dialysis Meeting 22 May 2014 Deux grands principes concernant la DP La dialyse péritonéale doit
More informationThe Nephrology Society of Thailand has been collect THE STATUS OF, AND OBSTACLES TO, CONTINUOUS AMBULATORY PERITONEAL DIALYSIS IN THAILAND
Proceedings of the 3rd Asian Chapter Meeting of the ISPD November 22 24, 2007, Hiroshima, Japan Peritoneal Dialysis International, Vol. 28 (2008), Supplement 3 0896-8608/08 $3.00 +.00 Copyright 2008 International
More informationDialysis, personalized. More options for your patients well being.
Dialysis, personalized. More options for your patients well being. Discover the advanced peritoneal dialysis (PD) system with improved features for added control and convenience during your patients treatment
More informationChapter III. Treatment Modalities for ESRD Patients. Treatment Modality Options. Key Words: Home hemodialysis. ESRD modality Hemodialysis
Annual Data Report Chapter III Key Words: Anemia Dialysis dose Dialyzer membrane ESRD modality Hemodialysis Home hemodialysis Peritoneal dialysis Transplant, renal CAPD S everal modalities are available
More informationHow to evaluate the peritoneal membrane?
How to evaluate the peritoneal membrane? B. Bammens Brussels, May 12 2016 BELGIUM How to evaluate a hemodialyzer? How to evaluate a hemodialyzer? How to evaluate a hemodialyzer? From: Robert W. Schrier
More informationGambrosol Trio, clinical studies 91 Glitazone, malnutrition-inflammationatherosclerosis
Subject Index Acidosis, see Metabolic acidosis Activated carbon, sorbents 337 Adipokines adipose tissue and systemic inflammation 169 functions 167 169 prospects for study in renal patients 171 Adiponectin,
More informationEffect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study
Kidney International, Vol. 64 (2003), pp. 649 656 DIALYSIS TRANSPLANTATION Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study WAI-KEI LO, YIU-WING HO, CHUN-SANG
More informationUrgent start PD: Putting the person first
Urgent start PD: Putting the person first Arsh Jain MD, FRCPC, MSc ADC 2019 Who can we target with urgent start PD? Late or not referred Early referral Urgent dialysis start HD catheter Facility HD Who
More information